InnovaRx Innova Health Strategies
PricingSign in

D71.1

Bookmark

Leukocyte adhesion deficiency

Filed alongside this entry 186

under Deficiency, deficient

Index entries, exactly as the book files them. This says they are listed together — not that any of them is documented in your chart.

Billable FY2027 2026-10-01 → 2027-09-30 FY2026–2027 only
How to use this page

Everything the published sources say about one code, on one page.

  1. Read the Excludes1 block first — it is the one that stops you coding this at all alongside another code.
  2. Excludes2, Code first, Use additional and Includes follow. A note inherited from a parent category is labelled with the category it came from, so you can see why it applies.
  3. Official Guidelines sit below. "Guidelines naming this code" cite the code or a range containing it; "Chapter guidance" is the general guidance for its chapter and is the weaker signal.
  4. Guideline text is quoted verbatim with its section number and page, so you can check it against the published document.
  5. Risk-model chips show which published CMS models map this code.

What this page does not do

  • Guidance is quoted, never paraphrased — a paraphrase of a coding rule is a different rule.
  • Medication candidates, where shown, are matched by condition *name* and are offered as candidates for you to judge. They are not "the drugs for this code".

All page guides →

Exclusions9never code together
D50-D89chapter
Excludes2
  • autoimmune disease (systemic) NOS (M35.9)M35.9
  • certain conditions originating in the perinatal period (P00-P96)P00-P96
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)Q00-Q99
  • endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
  • human immunodeficiency virus [HIV] disease (B20)B20
  • injury, poisoning and certain other consequences of external causes (S00-T88)S00-T88
  • neoplasms (C00-D49)C00-D49
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes6
D71.1code
Inclusion terms
  • LAD-I
  • LAD-II
  • LAD-III
  • Leukocyte adhesion deficiency type I
  • Leukocyte adhesion deficiency type II
  • Leukocyte adhesion deficiency type III
Official Guidelines1names this code

ICD-10-CM Official Guidelines for Coding and Reporting, quoted in full. Published by CMS and NCHS; in the public domain.

I.C.3 Chapter 3: Disease of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) names this code p.39

Reserved for future guideline expansion

Index entries leading here2
  • Deficiency, deficient
  • LAD (leukocyte adhesion deficiency) (LAD-I) (LAD-II) (LAD-III) D71.1
Alongside this code2same parent — D71
D71.8 Other functional disorders of polymorphonuclear neutrophils D71.9 Functional disorders of polymorphonuclear neutrophils, unsp
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC47 CMS28HCC115 ESRD21HCC47 ESRD24HCC47 HHS08HHS_HCC074

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2027
Parent
D71
Block
D70-D77
Siblings
2

Present FY2026–FY2027.